A comparison of natalizumab's effects on SDMT between pediatric-onset and adult-onset multiple sclerosis patients.
Puthenparampil M, Scialpi G, Gaggiola M, Zanotelli G, Miscioscia A, Berardi A, Riccardi A, Nosadini M, Sartori S, Perini P, Rinaldi F, Gallo P.
Puthenparampil M, et al. Among authors: rinaldi f.
Front Neurol. 2024 Nov 6;15:1475161. doi: 10.3389/fneur.2024.1475161. eCollection 2024.
Front Neurol. 2024.
PMID: 39574510
Free PMC article.